TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -1 | 10 | 17 | -4 | -2 | 14 | 6 |
| P | %wins | 50 | 100 | 100 | 50 | 50 | 50 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/31/12 14:21 | 5/27/12 | DSCI | Derma Sciences, Inc. | PA | Health | MdEq | Surgical & Medical Instrument | Obrien James T | NJ | D | M.d | 0 | 0.00 | 0 | 3 | 9 | 31 | D | 79 | -10 | 16 | 2 | -1 | -6 | 0 | -1 | 0 | -1 | 5 | 6 | 28 | 50 | |
4/18/12 21:47 | 4/16/12 | DSCI | Derma Sciences, Inc. | PA | Health | MdEq | Surgical & Medical Instrument | Obrien James T | NJ | D | M.d | 41 | 4.08 | 1 | 10 | 55 | 28 | D | 60 | -1 | 11 | 17 | -3 | -4 | -4 | 0 | 1 | 4 | 4 | 13 | 22 | 32 | |
9/19/08 18:36 | 9/18/08 | DSCI | Derma Sciences, Inc. | PA | Health | MdEq | Surgical & Medical Instrument | Obrien James T | NJ | D | P.e | 9 | 0.4400 | 0 | 20 | 25 | 102 | D | -38 | -29 | -49 | -42 | -33 | -28 | -28 | -17 | -2 | 6 | 10 | -10 | -32 | 40 | |
1/19/05 09:53 | 1/14/05 | DSCI | Derma Sciences, Inc. | PA | Health | Drug | Pharmaceutical Preparations | Obrien James T | NJ | D | P.d | 20 | 0.5000 | 0 | 40 | 96 | 82 | D | 37 | -60 | -26 | -16 | -16 | -7 | -22 | 2 | 0 | 13 | 23 | 2 | 29 | -12 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |